Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2423studies indexed1086with human data145registered trials2091carry a numeric findingLibrarian added 0 studies today
Showing 8 studiesSortNewest indexed ▾
B
grade
Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons.
CJC-1295 without DAC (Modified GRF 1-29) · The Journal of clinical endocrinology and metabolism · 1993 · ObservationalHigh-impact journal
Glucocorticoids inhibit growth hormone release by enhancing beta-adrenergic responsiveness, with significant effects observed in a controlled study of normal volunteers.
GH peak: 10.7 +/- 3.9 vs. 20.3 +/- 5.5 micrograms/L; DEX vs. P study, respectively, P < 0.05.
A
grade
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
CJC-1295 without DAC (Modified GRF 1-29) · The Journal of clinical endocrinology and metabolism · 2006 · RCTHigh-impact journal
CJC-1295 administration resulted in sustained increases in GH and IGF-I levels in healthy adults without serious adverse reactions.
Mean plasma GH concentrations increased by 2- to 10-fold for 6 d or more.
B
grade
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.
CJC-1295 without DAC (Modified GRF 1-29) · The Journal of clinical endocrinology and metabolism · 2006 · ObservationalHigh-impact journal
CJC-1295 significantly increases basal and mean GH levels and IGF-I production while preserving GH pulsatility, but the clinical implications of these changes remain unclear.
7.5-fold increase in basal GH levels, P < 0.0001.
C
grade
Synergistic antibacterial and osteogenic properties of micro-arc oxidation GO@Ag/SF composite coatings for the repair of infectious bone defects.
CJC-1295 without DAC (Modified GRF 1-29) · Bioactive materials · 2026 · Animal study · Preclinical
The GO@Ag/SF composite coating shows promise for enhancing antibacterial and osteogenic outcomes in bone defects, but human studies are needed to confirm its clinical utility.
Inhibition rates against S. aureus and E. coli were up to 98.3 ± 1.2%.
C
grade
An orthogonal transcription system enables high-efficiency rescue of measles virus-based vaccine vectors against multiple pathogens.
CJC-1295 without DAC (Modified GRF 1-29) · Synthetic and systems biotechnology · 2026 · Animal study · Preclinical
The new orthogonal transcription system significantly enhances the efficiency of rMeV vector rescue, showing promise for rapid vaccine development, though human studies are needed.
Rescue efficiency enhanced by more than 50-fold.
B
grade
A Step-Up Underwater Endoscopic Mucosal Resection Strategy with Rescue Underwater Injection Endoscopic Mucosal Resection for Non-Pedunculated Colorectal Lesions.
CJC-1295 without DAC (Modified GRF 1-29) · DEN open · 2026 · Observational · n=56
A step-up strategy using UEMR with conversion to UIEMR achieved 100% en bloc resection and negative margins in non-pedunculated colorectal lesions, with no adverse events reported.
En bloc resection achieved in 100% of lesions.
Showing 8 of 8